| Jul 9 |
Soligenix stock soars 300% on positive HyBryte study results
|
| Jul 9 |
Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
|
| Jun 14 |
A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference
|
| Jun 14 |
SNGX: Valuation Change Based on Reverse Split…
|
| Jun 7 |
Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
| Jun 5 |
Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication Trial
|
| May 31 |
Soligenix to effect 1-for-16 reverse stock split
|
| May 31 |
Soligenix Announces Reverse Stock Split
|
| May 29 |
Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting
|
| May 24 |
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
|
